ProfileGDS4814 / ILMN_2203073
TitleOvarian cancer xenograft tumor response to trastuzumab and pertuzumab
OrganismHomo sapiens


none trastuzumab pertuzumab trastuzumab and pertuzumab GSM780707 GSM780708 GSM780709 GSM780719 GSM780720 GSM780721 GSM780710 GSM780711 GSM780712 GSM780722 GSM780723 GSM780724 GSM780713 GSM780714 GSM780715 GSM780725 GSM780726 GSM780727 GSM780716 GSM780717 GSM780718 GSM780728 GSM780729 6% 1% 1% 15% 2% 0% 3% 4% 1% 5% 0% 2% 2% 15% 1% 1% 2% 1% 20% 2% 2% 2% 10% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM780707Untreated after 4 days (C1_1)39.80556
GSM780708Untreated after 4 days (C2_1)36.59211
GSM780709Untreated after 4 days (C3_1)35.80571
GSM780719Untreated after 4 days (C1_2)42.389215
GSM780720Untreated after 4 days (C2_2)37.8432
GSM780721Untreated after 4 days (C3_2)30.40570
GSM780710Trastuzumab treated after 4 days (T1_1)38.27533
GSM780711Trastuzumab treated after 4 days (T2_1)38.66274
GSM780712Trastuzumab treated after 4 days (T3_1)36.8081
GSM780722Trastuzumab treated after 4 days (T1_2)39.27915
GSM780723Trastuzumab treated after 4 days (T2_2)29.38960
GSM780724Trastuzumab treated after 4 days (T3_2)37.39382
GSM780713Pertuzumab treated after 4 days (P1_1)37.6522
GSM780714Pertuzumab treated after 4 days (P2_1)42.427315
GSM780715Pertuzumab treated after 4 days (P3_1)36.71851
GSM780725Pertuzumab treated after 4 days (P1_2)35.04141
GSM780726Pertuzumab treated after 4 days (P2_2)37.96792
GSM780727Pertuzumab treated after 4 days (P3_2)36.90211
GSM780716Trastuzumab and Pertuzumab treated after 4 days (TP1_1)43.564720
GSM780717Trastuzumab and Pertuzumab treated after 4 days (TP2_1)37.13132
GSM780718Trastuzumab and Pertuzumab treated after 4 days (TP3_1)37.81222
GSM780728Trastuzumab and Pertuzumab treated after 4 days (TP1_2)37.57392
GSM780729Trastuzumab and Pertuzumab treated after 4 days (TP2_2)41.269910